Erdafitinib

Back to search

Molecule Structure

Scientific Name

Erdafitinib

Description of the Drug

Erdafitinib is a fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB12147

Brand Name(s)

Balversa

Company Owner(s)

Janssen Biotech Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Fibroblast growth factor receptor PROTEIN FAMILY INHIBITOR CHEMBL2095217

Unichem Links

SureChEMBL SCHEMBL2583760
DrugBank DB12147
PubChem 67462786
PDBe 5SF
BindingDB 50525939
DrugCentral 5327
ChemicalBook CB42725628
Guide to Pharmacology 9039
GSRS bb001a81-ef00-4a74-9dad-972b3817df54
rxnorm ERDAFITINIB BALVERSA
ZINC ZINC000168520308